Hereditary sensory and autonomic neuropathies: types II, III, and IV

被引:153
作者
Axelrod, Felicia B. [1 ,2 ]
Simson, Gabrielle Gold-von [1 ,2 ]
机构
[1] NYU, Sch Med, Dept Pediat, New York, NY 10011 USA
[2] NYU, Sch Med, Dept Neurol, New York, NY USA
关键词
D O I
10.1186/1750-1172-2-39
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The hereditary sensory and autonomic neuropathies (HSAN) encompass a number of inherited disorders that are associated with sensory dysfunction (depressed reflexes, altered pain and temperature perception) and varying degrees of autonomic dysfunction (gastroesophageal reflux, postural hypotention, excessive sweating). Subsequent to the numerical classification of four distinct forms of HSAN that was proposed by Dyck and Ohta, additional entities continue to be described, so that identification and classification are ongoing. As a group, the HSAN are rare diseases that affect both sexes. HSAN III is almost exclusive to individuals of Eastern European Jewish extraction, with incidence of 1 per 3600 live births. Several hundred cases with HSAN IV have been reported. The worldwide prevalence of HSAN type II is very low. This review focuses on the description of three of the disorders, HSAN II through IV, that are characterized by autosomal recessive inheritance and onset at birth. These three forms of HSAN have been the most intensively studied, especially familial dysautonomia (Riley-Day syndrome or HSAN III), which is often used as a prototype for comparison to the other HSAN. Each HSAN disorder is likely caused by different genetic errors that affect specific aspects of small fiber neurodevelopment, which result in variable phenotypic expression. As genetic tests are routinely used for diagnostic confirmation of HSAN III only, other means of differentiating between the disorders is necessary. Diagnosis is based on the clinical features, the degree of both sensory and autonomic dysfunction, and biochemical evaluations, with pathologic examinations serving to further confirm differences. Treatments for all these disorders are supportive.
引用
收藏
页数:12
相关论文
共 64 条
[1]   PERIPHERAL NERVE ABNORMALITIES IN RILEY-DAY SYNDROME - FINDINGS IN ASURAL NERVE BIOPSY [J].
AGUAYO, AJ ;
NAIR, CPV ;
BRAY, GM .
ARCHIVES OF NEUROLOGY, 1971, 24 (02) :106-&
[2]   Familial dysautonomia is caused by mutations of the IKAP gene [J].
Anderson, SL ;
Coli, R ;
Daly, IW ;
Kichula, EA ;
Rork, MJ ;
Volpi, SA ;
Ekstein, J ;
Rubin, BY .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :753-758
[3]   Pattern of plasma levels of catecholamines in familial dysautonomia [J].
Axelrod, FB ;
Goldstein, DS ;
Holmes, C ;
Berlin, D ;
Kopin, IJ .
CLINICAL AUTONOMIC RESEARCH, 1996, 6 (04) :205-209
[4]   Fludrocortisone in patients with familial dysautonomia - Assessing effect on clinical parameters and gene expression [J].
Axelrod, FB ;
Goldberg, JD ;
Rolnitzky, L ;
Mull, J ;
Mann, SR ;
von Simson, GG ;
Berlin, D ;
Slaugenhaupt, SA .
CLINICAL AUTONOMIC RESEARCH, 2005, 15 (04) :284-291
[5]   Familial dysautonomia: a review of the current pharmacological treatments [J].
Axelrod, FB .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (04) :561-567
[6]   Familial dysautonomia [J].
Axelrod, FB .
MUSCLE & NERVE, 2004, 29 (03) :352-363
[7]   Survival in familial dysautonomia: Impact of early intervention [J].
Axelrod, FB ;
Goldberg, JD ;
Ye, XY ;
Maayan, C .
JOURNAL OF PEDIATRICS, 2002, 141 (04) :518-523
[8]   PRELIMINARY-OBSERVATIONS ON THE USE OF MIDODRINE IN TREATING ORTHOSTATIC HYPOTENSION IN FAMILIAL DYSAUTONOMIA [J].
AXELROD, FB ;
KREY, L ;
GLICKSTEIN, JS ;
ALLISON, JW ;
FRIEDMAN, D .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1995, 55 (1-2) :29-35
[9]   CONGENITAL SENSORY NEUROPATHIES - DIAGNOSTIC DISTINCTION FROM FAMILIAL DYSAUTONOMIA [J].
AXELROD, FB ;
PEARSON, J .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1984, 138 (10) :947-954
[10]  
AXELROD FB, 1981, PEDIATRICS, V67, P517